SecProbe.io

Filing text and metadata
Intelligence Terminal Search Probe Scores Topics IPO Watchlist Monthly Activity About API

SEC Company Response from MetaVia Inc. (MTVA) (CIK 0001638287) (MTVA) — Jun 20, 2016

MetaVia Inc. (MTVA) (CIK 0001638287)
Date: June 20, 2016 · CIK: 0001638287 · Accession: 0001104659-16-128349

AI Filing Summary & Sentiment

Sentiment
Urgency
Document Type
Confidence
SEC Posture
Company Posture

Summary

Reasoning

File numbers found in text: 333-210815

Date
June 20, 2016
Author
JEFFERIES LLC
Form
CORRESP
Company
MetaVia Inc. (MTVA) (CIK 0001638287)

Letter

June 20, 2016

VIA EDGAR

United States Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, DC 20549

Attention:

Suzanne Hayes

Joshua Samples

Lilyanna Peyser

Sharon Blume

Sasha Parikh

Re:

Gemphire Therapeutics Inc.

Registration Statement on Form S-1 (File No. 333-210815)

Ladies and Gentlemen:

Pursuant to Rule 460 of the General Rules and Regulations under the Securities Act of 1933, as amended, we wish to advise that between June 13, 2016 and the date hereof, approximately 941 copies of the Preliminary Prospectus dated June 13, 2016 were distributed to prospective underwriters, institutional investors and prospective dealers in connection with the above-captioned Registration Statement.

We wish to advise you that the participating underwriters have complied and will continue to comply with the requirements of Rule 15c2-8 under the Securities Exchange Act of 1934, as amended.

We hereby join in the request of the registrant that the effectiveness of the above-captioned Registration Statement, as amended, be accelerated to 4:00 p.m. Eastern Time, on Wednesday, June 22, 2016 or as soon thereafter as practicable.

[signature page follows]

Very truly yours,
JEFFERIES LLC

Show Raw Text
CORRESP
1
filename1.htm

June 20, 2016

VIA EDGAR

United States Securities and Exchange Commission
 Division of Corporation Finance
 100 F Street, N.E.
 Washington, DC  20549

Attention:

Suzanne Hayes

Joshua Samples

Lilyanna Peyser

Sharon Blume

Sasha Parikh

Re:

Gemphire Therapeutics Inc.

Registration   Statement on Form S-1 (File No. 333-210815)

Ladies and Gentlemen:

Pursuant to Rule 460 of the General Rules and Regulations under the Securities Act of 1933, as amended, we wish to advise that between June 13, 2016 and the date hereof, approximately 941 copies of the Preliminary Prospectus dated June 13, 2016 were distributed to prospective underwriters, institutional investors and prospective dealers in connection with the above-captioned Registration Statement.

We wish to advise you that the participating underwriters have complied and will continue to comply with the requirements of Rule 15c2-8 under the Securities Exchange Act of 1934, as amended.

We hereby join in the request of the registrant that the effectiveness of the above-captioned Registration Statement, as amended, be accelerated to 4:00 p.m. Eastern Time, on Wednesday, June 22, 2016 or as soon thereafter as practicable.

[signature page follows]

Very truly yours,

JEFFERIES LLC

RBC CAPITAL MARKETS, LLC

As representatives of the

several underwriters

JEFFERIES LLC

By:

/s/ Dustin Tyner

Name: Dustin Tyner

Title:  Managing Director

RBC CAPITAL MARKETS, LLC

By:

/s/ Lorenzo   Paoletti

Name: Lorenzo Paoletti

Title:  Director

[Signature Page to Acceleration Request of the Underwriters]